[PDF] Practice guideline update : corticosteroid treatment of Duchenne muscular dystrophy

Source:
American Academy of Neurology
Publisher:
American Academy of Neurology
Publication date:
01 February 2016

Abstract

Objective: To update the 2005 American Academy of Neurology (AAN) guideline on corticosteroid treatment of Duchenne muscular dystrophy (DMD). The following questions were asked: What is the efficacy of corticosteroids in DMD, what are their side effects, and what is the optimal dosing regimen? Are there useful interventions to maximize bone health in patients with DMD taking corticosteroids?